Xiangya Hospital of Central South University — Changsha, Hunan

Public research footprint of Xiangya Hospital of Central South University, compiled from the ClinicalTrials.gov public registry.

1,015

Registered studies

417

Active

258

Recruiting now

382

Completed

Stopped or withdrawn

Most-studied conditions

Psoriasis · Crohn Disease · HR Low-Positive/HER2-Negative Breast Neoplasms · Non-small Cell Lung Cancer (NSCLC)

Recently updated registry entries

NCT07746726 — Safety and Efficacy of HRS-9190 Compared to Rocuronium for Tracheal Intubation and Bolus… (Not Yet Recruiting)
NCT07242300 — Efficacy and Safety of Recombinant Botulinum Toxin Type A (Eveotox) for Injection in the… (Recruiting)
NCT06097260 — Randomized, Double-blind Study of Efficacy and Safety of Bexotegrast (PLN-74809) for… (Terminated)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Xiangya Hospital of Central South University?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.